Catalyst Wire Dossier Catalyst Wire Dossier

PUVA therapy (psoralen + ultraviolet A)

psoralen + ultraviolet A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PUVA therapy (psoralen + ultraviolet A), covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo. [EARLY_Phase 1]

See pricing